DNA Repair and Replication-Related Gene Signature Based on Tumor Mutation Burden Reveals Prognostic and Immunotherapy Response in Gastric Cancer

Figure 7

The estimation of two prognostic subtypes in immunotherapy response. (a–f) The expression of six immune checkpoint molecules (PD-L1, IAP, PD1, CTLA4, TIGIT, and TIM-3) in two prognostic subtypes. (g) Chi-squared test plot for immunotherapy in the responder. (h-i) Violin diagram showing the differential TIDE and TCIA between the high/low-risk groups.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)